Jun 03, 2022 2:00am EDT Lexaria Grants Exclusive License to Premier Wellness Science Co., Ltd. for Strategic and Long-Term Partnership in the Japanese Market
May 26, 2022 8:30am EDT Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space
May 25, 2022 8:30am EDT Lexaria Bioscience Corp. (NASDAQ: LEXX) Offers Breakthrough Delivery Tech in Hot Nicotine Space
Apr 14, 2022 8:45am EDT Lexaria's Pulmonary Hypertension Clinical Study HYPER-H21-3 Delivers Positive Results
